Signature Equity Partners’s Nuvalent NUVL Stock Holding History

Signature Equity Partners’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8	Closed	-$820	–	1665
2026 Q1	$820	Buy	+8	New	+$815	﹤0.01%	1299

Other funds holding NUVL

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Signature Equity Partners's NUVL Position: Q2 2026 in Review

Signature Equity Partners sold out of Nuvalent (NUVL) in Q2 2026, closing a stake of 8 shares — an estimated $820 sold.

Signature Equity Partners first reported a position in NUVL in Q1 2026 and held it in 1 quarter. The position peaked at $820 in Q1 2026. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

Signature Equity Partners reported no remaining Nuvalent position as of Q2 2026 after selling out during the quarter.
Signature Equity Partners sold 8 Nuvalent shares in Q2 2026, an estimated $820.
Signature Equity Partners first reported a position in Nuvalent in Q1 2026 and held it in 1 quarter.
Signature Equity Partners's Nuvalent position peaked at $820 in Q1 2026.
293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.